The surrogate physician has decided to report the Lancet issue

Published Date: 16 Feb 2023

The Lancet expressed concern about two papers written by an Italian doctor who is now on trial after being convicted in a Swedish court of causing bodily harm to a patient.

Read Full News

Latest News

Congo's Ebola Responders Decry Lack Of Medicine, Masks, Motorbikes

First responders fighting Democratic Republic of Congo's 17th Ebola outbreak say even basic supplies are scarce - from pain medicine, to motorbikes for contact tracing and...

Polypsychopharmacy on the Rise in Primary Care

A recent study shows that the concomitant use of two or more classes of psychotropic medication has risen among adult patients in Dutch primary care over a 10-year period.

A Post-Op Death, a Physician’s Personal Grief

Her brother’s death from a post-op pulmonary embolism left this cardiologist not only grieving but feeling guilty about the what-ifs.

10 Bucket List Vacation Ideas for Doctors

Discover the awe-inspiring destinations that top physicians' ultimate travel wish lists.

Medscape Dermatologist Compensation Report 2026

US dermatologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

High BMI, Low Activity Levels Linked to Chronic Pain

People with a high BMI or sedentary behavior have increased odds of experiencing chronic pain, although an interaction between these factors is not evident.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

First responders fighting Democratic Republic of Congo's 17th Ebola outbreak say even basic supplies are scarce - from pain medicine, to motorbikes for contact tracing and...

A recent study shows that the concomitant use of two or more classes of psychotropic medication has risen among adult patients in Dutch primary care over a 10-year period.

Her brother’s death from a post-op pulmonary embolism left this cardiologist not only grieving but feeling guilty about the what-ifs.

Discover the awe-inspiring destinations that top physicians' ultimate travel wish lists.

US dermatologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

People with a high BMI or sedentary behavior have increased odds of experiencing chronic pain, although an interaction between these factors is not evident.

News All Time

Medscape Gastroenterologist Compensation Report 2026

US gastroenterologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Medscape Family Physician Compensation Report 2026

US family physicians report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Medscape Internist Compensation Report 2026

US internists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Medscape Endocrinologist Compensation Report 2026

US endocrinologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Medscape Emergency Medicine Physician Compensation Report 2026

US emergency medicine physicians report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Medscape Cardiologist Compensation Report 2026

US cardiologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Polymyalgia Rheumatica: Key Symptoms and Treatment

Learn the key symptoms of polymyalgia rheumatica, as well as the overlap with giant cell arteritis.

Rates of Induced Labor Have Jumped in the Past Decade

Use of epidurals also on the rise

Hold GLP-1s Before Endoscopy? Clinical Trial Finds Retained Gastric Contents

Residual gastric volume precluded endoscopic examination

Knee Replacement: What Regional Pain Block Is Best for Outpatients?

Trial testing continuous versus single-shot adductor canal block produces a clear winner

Gabapentin, Pregabalin Increasingly Prescribed With Opioids

Millions of U.S. patients are still prescribed long-term opioids

Anesthesiologist Accused of Trying to Murder His Wife Convicted on Lesser Charge

Hawaii doctor's attorney plans to appeal

Jurors Deciding Whether Doctor Tried to Kill His Wife During a Hike in Hawaii

Gerhardt Konig is accused of having multiple plans to commit murder

Why Anesthesiologists Love Ketamine (And Why You Should Understand It)

Different doses lead to different effects on the body and the brain

Gabapentin, Pregabalin Tied to Higher Risks Early in Treatment

Drug poisoning rates rose, especially when used with other prescriptions

Building a Better Pre-Op Visit

It should never just be about checking a box

Recommended News For You

Should the UK introduce targeted prostate cancer screening? The case for and against

Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.

PFS in Multiple Myeloma Is Improved by Daratumumab Added to Standard Therapy.

Fear of hair loss might cause some to reject cancer treatment

Telemedicine services linked to reducing excess mortality

How the skin cancer virus outperforms the replication of host cells.

MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

Recommended Articles For You

Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts 

Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care 

Radiation in Oncology: Advances, Applications, and Accessibility 

Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast Cancer Patients Living Longer Post-Medicaid Expansion

2.

Error on the MGUS-Autoimmune Disease Association.

3.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

4.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

5.

Unified Neuro/Psych Residency Program: New Proposal.

1.

Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training

2.

Hemoglobin C: Understanding its Role in Sickle Cell Disease

3.

Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging

4.

Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer 

5.

The Growing Challenge of Haematological Malignancies in Older Adults

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

2.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

4.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

5.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot